Craig Bijou
Stock Analyst at B of A Securities
(3.75)
# 733
Out of 5,056 analysts
64
Total ratings
58.33%
Success rate
52.86%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $83.42 | +9.09% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $9.60 | -6.25% | 2 | Jul 9, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $28.40 | +195.77% | 4 | Apr 25, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $107.47 | +30.27% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $15.10 | +12.58% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $11.42 | +57.62% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $67.75 | +114.02% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $84.17 | +22.37% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $74.40 | +14.25% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $71.02 | +21.09% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $72.20 | +31.58% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $18.36 | +96.08% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.57 | +584.93% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $4.18 | +2,774.25% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.05 | +494.06% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $14.78 | -12.04% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $14.41 | +191.46% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $546.77 | -57.93% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $359.52 | -36.03% | 4 | Jul 26, 2019 |
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $83.42
Upside: +9.09%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $9.60
Upside: -6.25%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $28.40
Upside: +195.77%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $107.47
Upside: +30.27%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $15.10
Upside: +12.58%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $11.42
Upside: +57.62%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $67.75
Upside: +114.02%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $84.17
Upside: +22.37%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $74.40
Upside: +14.25%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $71.02
Upside: +21.09%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $72.20
Upside: +31.58%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $18.36
Upside: +96.08%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.57
Upside: +584.93%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $4.18
Upside: +2,774.25%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $5.05
Upside: +494.06%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $14.78
Upside: -12.04%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $14.41
Upside: +191.46%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $546.77
Upside: -57.93%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $359.52
Upside: -36.03%